This announcement is a separate document:
广济药业：北京市京师（武汉）律师事务所关于湖北广济药业股份有限公司回购注销2021年限制性股票激励计划部分限制性股票之法律意见书
Hubei Guangji Pharmaceutical: Legal Opinion of Beijing Jingshi (Wuhan) Law Firm on the Repurchase and Cancellation of Part of the Restricted Stock Incentive Plan of Hubei Guangji Pharmaceutical Co., Ltd. in the 2021 Restricted Stock Incentive Plan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.